Serum beta-2-microglobulin (beta-2-M) levels in heart transplant patients (HTP). 1996

W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
Department and Clinic of Internal Medicine, Silesian Academy of Medicine, Zabrze, Poland.

The present paper aim to answer following questions: 1. What is serum beta-2-M levels in HTP? 2. Does significant correlations between serum beta-2-M levels and serum creatinine levels or creatinine clearance (inulin clearance) exit? 3. Does any significant correlation between serum beta-2-M levels and blood cyclosporine A concentration exit? Three groups of subjects were studied. The first group consisted of 33 heart transplant patients (HTP), the second group consisted of 12 patients with small decline kidney function, and the third one consisted of 36 healthy subjects. In all examined subjects serum beta-2-M (RIA) creatinine, creatinine and inulin (steady state dosis method) clearance were assessed. CONCLUSIONS 1. In observed HTP serum beta-2-M level is significantly higher then in controls and patients with small decline kidney function; 2. A significant correlation between kidney function and -2-M level in HTP as well as in other examined groups subjects exit; 3. Presence a significant positive correlation between serum beta-2-M level and blood cyclosporine A concentration suggest that beta-2-M level can be a good parametr to define cyclosporine A tubular toxicity.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400
D051437 Renal Insufficiency Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE. Kidney Insufficiency,Kidney Failure,Renal Failure,Failure, Kidney,Failure, Renal,Failures, Kidney,Failures, Renal,Insufficiency, Kidney,Kidney Failures,Kidney Insufficiencies,Renal Failures,Renal Insufficiencies

Related Publications

W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
June 1987, Transplantation,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
November 1994, The International journal of artificial organs,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
January 1989, Clinical and laboratory haematology,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
November 1980, Urology,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
August 1986, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
June 1983, Transplantation,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
May 1979, The Journal of urology,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
January 1985, Harefuah,
W Grzeszczak, and E Zukowska-Szczechowska, and M Zembala, and Z Religa, and W Pokrzywnicki, and A Kochanska-Dziurowicz
October 1989, Journal of internal medicine,
Copied contents to your clipboard!